BioCentury | Oct 27, 2017
Company News
Fujirebio developing companion diagnostic for Morphotek's farletuzumab
...The Morphotek Inc. subsidiary of Eisai Co. Ltd. (Tokyo:4523) granted Fujirebio Inc. (Tokyo, Japan) exclusive, worldwide rights...
...Eisai Co. Ltd. (Tokyo:4523), Tokyo, Japan Fujirebio Inc. , Tokyo, Japan Business: Cancer Jaime De Leon farletuzumab Eisai Co. Ltd. Fujirebio Inc. Morphotek...
...Eisai Co. Ltd. (Tokyo:4523), Tokyo, Japan Fujirebio Inc. , Tokyo, Japan Business: Cancer Jaime De Leon farletuzumab Eisai Co. Ltd. Fujirebio Inc. Morphotek...